We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK's Medicines and Healthcare products Regulatory
Agency (MHRA) has given Chiron the go-ahead to operate its Liverpool plant for
the first time since the vaccine-manufacturing facility's license was pulled
five months ago.
The proliferation of clinical trial registries has started raising red flags
among drug companies, some of which are starting to express concerns that making
all clinical data publicly available will leave valuable trade secrets exposed.
Pharma major Orchid Chemicals & Pharmaceuticals said the U.S. FDA has completed
inspection of its state-of-the-art formulations facility located at Irungattukottai
in Chennai.
Chiron and the Respiratory Disease Network have reached a settlement regarding
the lawsuit initiated by Chiron in October 2004, relating to product marketing
practices for a cystic fibrosis treatment.
Washington University School of Medicine received a $14 million, five-year grant
to find better ways to prevent and treat heart disease in patients with diabetes,
it said Monday.
A study released at the American College of Cardiology in Orlando, Fla., showed
that a combination of Norvasc, from Pfizer, and Aceon, co-marketed in the U.S.
by Solvay and CV Therapeutics outperformed an older combination of blood-pressure
therapies.
Cardinal Health, the leading provider of products and services supporting the
healthcare industry, has announced the opening of a new manufacturing plant
in Las Piedras, Puerto Rico for its Pyxis Products business.
Millennium Pharmaceuticals has landed about $40 million in licensing fees and
milestone payments from collaborations with pharmaceutical giants GlaxoSmithKline
Group (GSK) in London and Johnson & Johnson Pharmaceutical Research and
Development LLC in New Jersey.
United Therapeutics, coming off its first-ever profitable year, says it has
received regulatory approval in France for Remodulin, its treatment for pulmonary
hypertension, a rare lung disorder.